X0306 4 2013-04-25 0 0001053369 ELITE PHARMACEUTICALS INC /NV/ ELTP 0001442002 EPIC PHARMA LLC 227-15 NORTH CONDUIT AVE LAURELTON NY 11413-3134 0 0 1 0 Common Stock 2013-04-25 4 D 0 150000 0.08 D 14910666 I see footnote Common Stock 2013-04-26 4 D 0 243926 0.0802 D 14666740 I see footnote Common Stock 2013-04-26 4 C 0 8230453 0 A 22897193 I see footnote Common Stock 2013-04-29 4 J 0 13367481 0.0369 D 9529712 I see footnote Common Stock 2013-04-29 4 D 0 130000 0.08 D 9399712 I see footnote Series E Convertible Preferred Stock 0.0243 2013-04-26 4 C 0 200 1000 D 2013-04-26 Common Stock 8230453 1600 I see footnote Warrants 0.0625 2013-04-26 4 J 0 13272999 0 D 2009-10-30 2016-10-30 Common Stock 13272999 26727001 I see footnote The reporting person, Epic Pharma, LLC ("EP"), is an equity owner of Epic Investments, LLC ("EI"), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer. EP and EI are both owned, wholly or in part, and are operated by Ram Potti, Ashok G. Nigalaye and Jeenarine Narine, each of whom is a director of the issuer. The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI. Conversion of Series E Preferred Stock of issuer at the rate of approximately 41,152.26 shares of common for each share of such preferred stock. N/A Disposition of shares to its members Disposition of warrants to its members Ram Potti 2013-04-29